Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/12754039/ below:

Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival

Affiliations

• ¹ Department of Surgery, University of Szeged, Szeged, Hungary. fj@surg.szote.u-szeged.hu

• PMID: 12754039
• DOI: 10.1016/s1010-7940(03)00084-8

Item in Clipboard

József Furák et al. Eur J Cardiothorac Surg. 2003 May.

• ¹ Department of Surgery, University of Szeged, Szeged, Hungary. fj@surg.szote.u-szeged.hu

• PMID: 12754039
• DOI: 10.1016/s1010-7940(03)00084-8

Item in Clipboard

Objective: The prevalence of pulmonary adenocarcinoma has risen worldwide. Bronchioloalveolar carcinoma (BAC) was studied with regard to whether it exhibits a similar tendency, and its typical features were analysed.

Methods: Between 1992 and 2001, 278 lung resections were carried out for adenocarcinoma. Of these, 67 (24.1%) proved to involve BAC. Whereas BAC accounted for 6.9% of the cases in 1992, in 2001 the proportion was 46.9%. There were 37 men (55.2%) and 30 women (44.7%); the average age was 60.5 years. 58.2% of them had no complaints. Of the 26 non-smokers, 69.2% were women; of the 41 smokers, 29.2% were women. In consequence of the tumour, 49 lobectomies, three bilobectomies, six pneumonectomies and nine wedge resections were performed.

Results: The surgical mortality was 1.6%. The pathology revealed that 26 (38.8%) tumours were in stage I/A. In 15 cases (22.4%), tuberculosis (TB) could be revealed besides the BAC: by skin tests in four cases, by CT in three cases, by case history in four cases, and by pathology in four cases. For the overall group of 67 patients, the 5-year survival rate was 61.9%, and the mean survival time was 75.7 months. The 5-year survival rate among the women (74%) was significantly better than that among the men (37%) (P=0.030). There was no significant difference in survival with regard to the multiple BAC (85%). The 5-year survival rate was significantly worse in the mixed BAC group (20%) than in the non-mucinous (62.7%) and in mucinous (59%) group. The overall 5-year survival rate among the smokers and TB patients was 61 and 79%, respectively, which is higher than that among the non-smokers (47%) and non-TB patients (56%). The survival rate for the wedge resection cases was 37%, which was lower than that for the cases involving major resections (60%) (P=0.939).

Conclusion: BAC has a favourable survival, particularly in women. In spite of this, resection smaller than lobectomy is recommended only as a compromise. A multiple appearance does not imply a worse survival. The best survival rate was found in the non-mucinous BAC among the histological groups. TB seems to be frequent among BAC patients.

PubMed Disclaimer

• [The occurrence of bronchioloalveolar lung cancer among our patients].

  Furák J, Troján I, Szôke T, Tiszlavicz L, Morvay Z, Balogh A. Furák J, et al. Magy Onkol. 2003;47(4):349-53. Epub 2004 Jan 11. Magy Onkol. 2003. PMID: 14716429 Hungarian.

• Surgical resection for patients with mucinous bronchioloalveolar carcinoma.

  Oka S, Hanagiri T, Uramoto H, Baba T, Takenaka M, Yasuda M, Ono K, So T, Takenoyama M, Yasumoto K. Oka S, et al. Asian J Surg. 2010 Apr;33(2):89-93. doi: 10.1016/S1015-9584(10)60015-2. Asian J Surg. 2010. PMID: 21029945

• Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.

  Sakurai H, Dobashi Y, Mizutani E, Matsubara H, Suzuki S, Takano K, Shindo S, Matsumoto M. Sakurai H, et al. Ann Thorac Surg. 2004 Nov;78(5):1728-33. doi: 10.1016/j.athoracsur.2004.05.017. Ann Thorac Surg. 2004. PMID: 15511463 Review.

• Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung.

  Rena O, Papalia E, Ruffini E, Casadio C, Filosso PL, Oliaro A, Maggi G. Rena O, et al. Eur J Cardiothorac Surg. 2003 Mar;23(3):409-14. doi: 10.1016/s1010-7940(02)00830-8. Eur J Cardiothorac Surg. 2003. PMID: 12614815

• Surgery for bronchioloalveolar carcinoma and "very early" adenocarcinoma: an evolving standard of care?

  Rusch VW, Tsuchiya R, Tsuboi M, Pass HI, Grunenwald D, Goldstraw P. Rusch VW, et al. J Thorac Oncol. 2006 Nov;1(9 Suppl):S27-31. J Thorac Oncol. 2006. PMID: 17409998 Review.

• Expression of FAK and PTEN in bronchioloalveolar carcinoma and lung adenocarcinoma.

  Wang C, Yang R, Yue D, Zhang Z. Wang C, et al. Lung. 2009 Mar-Apr;187(2):104-9. doi: 10.1007/s00408-008-9130-6. Epub 2009 Feb 26. Lung. 2009. PMID: 19242756

• International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

  Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D. Travis WD, et al. J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221. J Thorac Oncol. 2011. PMID: 21252716 Free PMC article. Review.

• Clinical features of bronchioloalveolar carcinoma with new histologic and staging definitions.

  Ebbert JO, Chhatwani L, Aubry MC, Wampfler J, Stoddard S, Zhang F, Qiao G, de Andrade M, Yang P. Ebbert JO, et al. J Thorac Oncol. 2010 Aug;5(8):1213-20. doi: 10.1097/JTO.0b013e3181e2f645. J Thorac Oncol. 2010. PMID: 20592627 Free PMC article.

• Comparative study of imaging and pathology of primary mucinous adenocarcinoma with different imaging manifestations.

  Han J, Gao J, Chen D, Du M, Wu Y, Ma X, Xie M, Han H, Wu C, Xue X. Han J, et al. Clin Respir J. 2024 Apr;18(4):e13750. doi: 10.1111/crj.13750. Clin Respir J. 2024. PMID: 38616354 Free PMC article.

• Case report: Positron emission tomography fails to detect pulmonary adenocarcinoma recurrence after radiofrequency ablation.

  Odenthal C, Steinke K. Odenthal C, et al. J Radiol Case Rep. 2013 Nov 1;7(11):15-23. doi: 10.3941/jrcr.v7i11.1448. eCollection 2013 Nov. J Radiol Case Rep. 2013. PMID: 24421926 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3